: 目的探讨泛耐药肺炎克雷伯菌感染患者的药物治疗. 方法以临床药师参与治疗的泛耐药肺炎克雷
伯菌肺部感染及血流感染患者的抗感染方案为例, 结合临床实践经验和最新文献进展, 分析探讨…

… The patient was treated intermittently with intravenous antibiotics (Ceftriaxone sodium and
Vancomycin) for approximately 10 months, but with minimal effect. The Glasgow Coma Scale …

… , patients treated by tigecycline have significant more treatment failure and septic shock.
Therefore, tigecycline is not recommended in critically ill patients. … mortality of patients receiving …

… Population pharmacokinetics of intravenous polymyxin B in critically ill patients:implications …
Pharmacokinetics of intravenous polymyxin B in critically ill patients[J]. Clin Infect Dis,2008,…

… Colistin serum concentrations after intravenous administration in critically ill patients with
serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, …

: 目的对不同替加环素治疗方案对重症监护室(ICU) 泛耐药鲍曼不动杆菌肺部感染的临床疗效和
安全性进行对比分析, 为替加环素的合理用药提供临床依据. 方法回顾性分析我院ICU 2014 年1 …

… The concentration of meropenem in the patient plasma sample was between 0.167 8 and
47.678 8 μg·… Conclusion: This method is successfully applied to the pharmacokinetic study of …

… Pharmacokinetics of ambroxol and clenbuterol tablets in healthy Chinese volunteers [J].
Int J Clin Exp Med, 2015, 8(10): 18744-18750 [12] Ni Y, Hou L, Chen L, et al. Bioequivalence …

… Comparison of methods for estimating glomerular filtration rate in critically ill patients with …
Pharmacokinetic optimisation of vancomycin therapy[J]. Clin Pharmacokinet,1995,28(4): 327…

… When patients have stages 2 or 3 AKI or oliguria, due to the significant pharmacokinetic
changes of renal … However, for patients with sepsis and AKI, safer antibiotics such as β-lactam …